Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Alprolix drug?

See the DrugPatentWatch profile for Alprolix

Alprolix is a brand-name drug for hemophilia B. Here’s a quick overview:

- What it is: Eftrenonacog alfa, a recombinant factor IX (FIX)Fc fusion protein. The Fc portion extends the half-life of FIX, so patients don’t need as frequent infusions.

- What it’s for: Used to prevent bleeding (prophylaxis) and to treat bleeds in people with congenital factor IX deficiency (hemophilia B). It can also be used for perioperative management.

- How it’s given: Intravenous (IV) infusion. Dosing is individualized by a healthcare provider and is often scheduled every 7 to 14 days for prophylaxis, with dosing adjusted based on factor IX levels and bleeding history. On-demand treatment of bleeds is also possible.

- Who should use it: Adults and children with hemophilia B who need FIX replacement therapy.

- Safety notes: Common side effects include injection-site reactions, headache, and fever. Inhibitors to factor IX can rarely develop, which may reduce effectiveness. Serious allergic reactions or thromboembolic events can occur with improper dosing. Most people need to be monitored by a healthcare provider.

- Practical points: Stored refrigerated and infused in a clinical or home setting by someone trained in IV administration after proper instruction.

If you’d like, tell me what you want to know next (dosing examples, side effects in more detail, how it compares with other products, or safety monitoring).



Other Questions About Alprolix :

alprolix pediatric data Alprolix extended half life? Alprolix brand name? Alprolix formulation? What is alprolix? Alprolix uspi? Alprolix company?